Found 19 matching trials
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) PHASE2 The main purpose of this study is to evaluate whether treatment with donane...
Show More Learn More & Join Trial
A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ) PHASE2 The purpose of this study is to evaluate the safety, tolerability and effic...
Show More Location
Banner Alzheimer's Institute
Learn More & Join Trial
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) PHASE3 The reason for this study is to see how safe and effective the study drug d...
Show More Status
Active Not Recruiting
Location
Gilbert Neurology
Learn More & Join Trial
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5) PHASE3 The reason for this study is to assess the safety and efficacy of donanemab...
Show More Status
Active Not Recruiting
Location
Hospital Italiano de Buenos Aires
Learn More & Join Trial
A Study of Donanemab (LY3002813) in Healthy Participants PHASE1 The main purpose of this study is to assess how fast donanemab (LY3002813) ...
Show More Location
ICON Early Phase Services Lenexa Center
Learn More & Join Trial
Alzheimer's Tau Platform: Master Protocol PHASE2 The goal of the Alzheimer's Tau Platform (ATP) is to evaluate the safety an...
Show More Location
University of California, San Francisco
Learn More & Join Trial
A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4) PHASE3 The main purpose of this study is to compare donanemab to aducanumab on bra...
Show More Location
Neurology Center of North Orange County
Learn More & Join Trial
A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT) PHASE2 The main goals of this study are to further determine whether the study dru...
Show More Location
Banner Alzheimer's Institute
Learn More & Join Trial
Restoring Vascular and Insulin Function To Augment Anti-Amyloid Therapy in Alzheimer's Disease PHASE2 The purpose of this study is to find out what effects (good and bad) the st...
Show More Location
Wake Forest Alzheimer's Disease Research Center (ADRC) Sticht Center for Healthy Aging
Learn More & Join Trial
A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease N/A The main purpose of this study is to evaluate the long-term effectiveness o...
Show More Location
Rehabilitation & Neurological Services
Learn More & Join Trial